A 55-year-old male presented in surgery OPD with yellow-coloured sclera and greasy stools. On detailed examination, he was diagnosed with carcinoma of head of pancreas. Based on these clinical findings, discuss the following :
(i) Serum markers of cholestasis
(ii) Biochemical findings in serum, urine and stool sample in this patient
(iii) Cause of greasy stools
10 marks · directive: Discuss
The core of a good answer
A tumour in the head of the pancreas can block the bile duct, producing post-hepatic (obstructive) cholestasis: serum shows raised conjugated bilirubin and highly raised alkaline phosphatase, with GGT and 5'-nucleotidase helping to localise the ALP to the hepatobiliary system; urine is dark with bilirubin but urobilinogen is decreased or absent; stools are pale and greasy because bile salts and pancreatic lipase fail to reach the gut.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
The three parts move from markers, to the full pattern in serum, urine and stool, to the mechanism of steatorrhoea. A good answer links each finding to obstruction of the ducts and may use a short table comparing pre-hepatic, hepatic and post-hepatic jaundice.
Answer outline
Introduction
About 60 to 70 percent of pancreatic adenocarcinomas arise in the head of the gland; the tumour can block the bile duct, so jaundice is often the first symptom noticed.
(i) Serum markers of cholestasis
- Alkaline phosphatase (ALP): highly raised in post-hepatic jaundice; a rise above 10 times the upper limit strongly suggests intrahepatic or extrahepatic cholestasis.
- Gamma-glutamyl transferase (GGT) and 5'-nucleotidase: help localise a raised ALP to the hepatobiliary system; a normal GGT raises the possibility of a non-hepatic source such as bone.
- Conjugated (direct) bilirubin: raised; total bilirubin raised.
- Serum bile acids: elevation would be the optimal test for cholestasis, though the test is usually not available in most clinical settings.
- Lipids: cholestatic liver disease can affect lipids and possibly lead to dyslipidaemia.
(ii) Findings in serum, urine and stool
- Serum: conjugated bilirubin raised, unconjugated bilirubin normal; ALP highly raised; fat-soluble vitamin K may be deficient because of reduced bile flow.
- Urine: dark, because water-soluble conjugated bilirubin is filtered into urine; bilirubin present; urobilinogen decreased or absent, because bilirubin does not reach the gut to be converted.
- Stool: pale or white because no stercobilin is formed; bulky, oily, foul smelling and difficult to flush (steatorrhoea); faecal fat can be measured over a defined time, often five days.
(iii) Cause of greasy stools
- Bile salt deficiency in the gut: loss of bile salts reduces micelle formation, so fat absorption fails.
- Exocrine pancreatic insufficiency: lack of pancreatic lipase leads to poor digestion of fat.
- Consequences: deficiency of vitamins A, D, E or K due to reduced bile flow; lack of pancreatic exocrine products is treated with pancreatin, best taken with food.
Conclusion
The patient's yellow sclera and greasy stools both follow from obstruction at the head of the pancreas, which stops bile, and often pancreatic enzymes, from reaching the gut.
Examples and data to cite
- A blocked bile duct can enlarge the gallbladder, which can sometimes be felt as a swollen lump just under the ribs on the right side.
- CA19-9 has a sensitivity of 80 percent and specificity of 73 percent for pancreatic adenocarcinoma and is used to monitor known cases rather than to diagnose.
Facts to remember
- About 60 to 70 percent of pancreatic adenocarcinomas occur in the head of the pancreas.
- In post-hepatic jaundice urine urobilinogen is lowered or absent and stools are pale to white.
- Conjugated hyperbilirubinaemia is present in 80 percent of patients with extrahepatic cholestasis.
- About 5 percent of people lack the Lewis (a) antigen and cannot produce CA19-9.
- Steatorrhoea results from loss of bile salts, which reduces micelle formation, or from lack of pancreatic lipase.